Bitpanda makes it easy for you to invest in Hikma Pharmaceuticals from as little as €1. Invest 24/7 with zero commissions and tight spreads.
*Bitpanda Stocks are contracts replicating an underlying stock or ETF.
Create a Bitpanda account and confirm your email address.
Confirm your identity with one of our trusted verification partners and deposit funds.
You’re all set! Start investing with Bitpanda Stocks in Hikma Pharmaceuticals and over 2,500 other digital assets.
Hikma Pharmaceuticals Plc engages in developing, manufacturing and marketing branded and non-branded generic pharmaceutical products. It operates through the following segments: Branded, Injectables, Generics and Others. The Branded segment sells branded generics and in-licensed patented products in the Middle East and North Africa. The Injectables segment includes generic injectable products distributed globally and primarily used in hospitals. The Generics segment focuses on oral and other non-injectable generic products and is sold in the U.S. retail market. The Others segment comprises of Arab Medical Containers Ltd., International Pharmaceutical Research Center Ltd. and the chemicals division of Hikma Pharmaceuticals Ltd. (Jordan). The company was founded by Samih Taleb Darwazah in 1978 and is headquartered in London, the United Kingdom.